Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio
SUVRETTA CAPITAL MANAGEMENT, LLC Performance:
2025 Q3: 12.91%YTD: 19.64%2024: 13.58%
Performance for 2025 Q3 is 12.91%, and YTD is 19.64%, and 2024 is 13.58%.
About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings
SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in NEW YORK, NY. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.2 Billions. In it's latest 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $3.9 Billions as of 30 Sep, 2025.
The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are ARQT, BNTC, META. The fund has invested 5.1% of it's portfolio in ARCUTIS BIOTHERAPEUTICS INC and 3.5% of portfolio in BENITEC BIOPHARMA INC.
The fund managers got completely rid off GE HEALTHCARE TECHNOLOGIES I, DATADOG INC (DDOG) and MODERNA INC (MRNA) stocks. They significantly reduced their stock positions in DICKS SPORTING GOODS INC (DKS), 89BIO INC (ETNB) and AMAZON COM INC (AMZN). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in KEURIG DR PEPPER INC (KDP), ADVISORSHARES TR (ACT) and AVIDITY BIOSCIENCES INC (RNA). The fund showed a lot of confidence in some stocks as they added substantially to REGENERON PHARMACEUTICALS (REGN), COMPASS THERAPEUTICS INC (CMPX) and THERMO FISHER SCIENTIFIC INC (TMO).
The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are ARQT, BNTC, META. The fund has invested 5.1% of it's portfolio in ARCUTIS BIOTHERAPEUTICS INC and 3.5% of portfolio in BENITEC BIOPHARMA INC.
The fund managers got completely rid off GE HEALTHCARE TECHNOLOGIES I, DATADOG INC (DDOG) and MODERNA INC (MRNA) stocks. They significantly reduced their stock positions in DICKS SPORTING GOODS INC (DKS), 89BIO INC (ETNB) and AMAZON COM INC (AMZN). SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in KEURIG DR PEPPER INC (KDP), ADVISORSHARES TR (ACT) and AVIDITY BIOSCIENCES INC (RNA). The fund showed a lot of confidence in some stocks as they added substantially to REGENERON PHARMACEUTICALS (REGN), COMPASS THERAPEUTICS INC (CMPX) and THERMO FISHER SCIENTIFIC INC (TMO).
SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that SUVRETTA CAPITAL MANAGEMENT, LLC made a return of 12.91% in the last quarter. In trailing 12 months, it's portfolio return was 18.05%.
New Buys
| Ticker | $ Bought |
|---|---|
| keurig dr pepper inc | 40,050,700 |
| advisorshares tr | 34,329,900 |
| avidity biosciences inc | 32,677,500 |
| prokidney corp | 29,865,900 |
| salesforce inc | 29,684,200 |
| marvell technology inc | 22,892,300 |
| servicenow inc | 20,246,200 |
| snowflake inc | 20,119,100 |
New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC
Additions
| Ticker | % Inc. |
|---|---|
| regeneron pharmaceuticals | 105 |
| compass therapeutics inc | 97.23 |
| thermo fisher scientific inc | 69.62 |
| ferguson enterprises inc | 61.48 |
| home depot inc | 50.94 |
| danaher corporation | 46.42 |
| unitedhealth group inc | 41.5 |
| abbott labs | 25.91 |
Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| dicks sporting goods inc | -50.75 |
| 89bio inc | -41.73 |
| amazon com inc | -15.17 |
| ultragenyx pharmaceutical in | -11.37 |
| arcutis biotherapeutics inc | -9.17 |
| eyepoint pharmaceuticals inc | -8.99 |
| insmed inc | -8.79 |
| taiwan semiconductor mfg ltd | -7.72 |
SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| prokidney corp | -7,307,260 |
| taysha gene therapies inc | -7,432,310 |
| ge healthcare technologies i | -39,426,000 |
| moderna inc | -14,268,500 |
| pepgen inc | -333,000 |
| kymera therapeutics inc | -12,001,000 |
| datadog inc | -24,022,500 |
| onestream inc | -936,164 |
SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks
Sector Distribution
SUVRETTA CAPITAL MANAGEMENT, LLC has about 42% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 42 |
| Others | 25.7 |
| Technology | 11.2 |
| Consumer Cyclical | 6 |
| Communication Services | 4.3 |
| Consumer Defensive | 4.1 |
| Financial Services | 3.9 |
| Industrials | 2.8 |
Market Cap. Distribution
SUVRETTA CAPITAL MANAGEMENT, LLC has about 40.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 25.6 |
| MEGA-CAP | 25.4 |
| SMALL-CAP | 21.5 |
| LARGE-CAP | 15.2 |
| MICRO-CAP | 7.1 |
| MID-CAP | 5 |
Stocks belong to which Index?
About 62.3% of the stocks held by SUVRETTA CAPITAL MANAGEMENT, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 37.7 |
| S&P 500 | 36.6 |
| RUSSELL 2000 | 25.7 |
SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC
SUVRETTA CAPITAL MANAGEMENT, LLC has 90 stocks in it's portfolio. About 30.2% of the portfolio is in top 10 stocks. RARE proved to be the most loss making stock for the portfolio. ETNB was the most profitable stock for SUVRETTA CAPITAL MANAGEMENT, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.02 | 4,990 | 640,467 | unchanged | 0.00 | ||
| AADI | whitehawk therapeutics inc | 0.18 | 3,700,000 | 7,030,000 | unchanged | 0.00 | ||
| ABC | cencora inc | 0.10 | 12,488 | 3,902,880 | unchanged | 0.00 | ||
| ABEO | abeona therapeutics inc | 0.36 | 2,676,000 | 14,129,300 | unchanged | 0.00 | ||
| ABT | abbott labs | 0.17 | 51,020 | 6,833,620 | added | 25.91 | ||
| ACT | advisorshares tr | 0.88 | 7,167,000 | 34,329,900 | new | |||
| ALGN | align technology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMD | advanced micro devices inc | 1.65 | 398,799 | 64,521,700 | unchanged | 0.00 | ||
| AMZN | amazon com inc | 1.23 | 218,547 | 47,986,400 | reduced | -15.17 | ||
| APLS | apellis pharmaceuticals inc | 1.67 | 2,878,000 | 65,129,100 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 5.06 | 10,478,000 | 197,510,000 | reduced | -9.17 | ||
| AURA | aura biosciences inc | 0.69 | 4,372,880 | 27,024,400 | unchanged | 0.00 | ||
| AVTR | avantor inc | 0.02 | 71,850 | 896,688 | unchanged | 0.00 | ||
| BAC | bank america corp | 1.53 | 1,160,330 | 59,861,400 | added | 25.14 | ||
| BAX | baxter intl inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BIIB | biogen inc | 0.60 | 168,190 | 23,560,100 | added | 10.73 | ||
| BNTC | benitec biopharma inc | 3.55 | 9,876,510 | 138,567,000 | unchanged | 0.00 | ||
| BSX | boston scientific corp | 0.88 | 353,561 | 34,518,200 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 1.26 | 14,101,200 | 49,354,100 | added | 97.23 | ||
| COF | capital one finl corp | 1.30 | 238,770 | 50,757,700 | added | 22.98 | ||